SLC2A4 and breast cancer: (80) found that highly expressed ALKBH5 decreases m6A abundance in the 3’-UTR of GLUT4 mRNA and suppresses the degradation of GLUT4 transcripts by YTHDF2-mediated m6A reading, thus promoting glycolysis and resistance to HER2-targeted therapy in BC.